Cargando…

Classic Kaposi's sarcoma in morocco: clinico -epidemiological study at the national institute of oncology

BACKGROUND: Classic Kaposi's sarcoma (CKS) is a rare disease likely associated with human herpes virus 8 (HHV-8) infection, and occurs predominantly in Jewish, Mediterranean and middle eastern men .There is a dearth of data in Moroccan patients with CKS regarding epidemiology, clinical characte...

Descripción completa

Detalles Bibliográficos
Autores principales: Errihani, Hassan, Berrada, Narjisse, Raissouni, Soundouss, Rais, Fadoi, Mrabti, Hind, Rais, Ghizlane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266214/
https://www.ncbi.nlm.nih.gov/pubmed/22078023
http://dx.doi.org/10.1186/1471-5945-11-15
_version_ 1782222147832250368
author Errihani, Hassan
Berrada, Narjisse
Raissouni, Soundouss
Rais, Fadoi
Mrabti, Hind
Rais, Ghizlane
author_facet Errihani, Hassan
Berrada, Narjisse
Raissouni, Soundouss
Rais, Fadoi
Mrabti, Hind
Rais, Ghizlane
author_sort Errihani, Hassan
collection PubMed
description BACKGROUND: Classic Kaposi's sarcoma (CKS) is a rare disease likely associated with human herpes virus 8 (HHV-8) infection, and occurs predominantly in Jewish, Mediterranean and middle eastern men .There is a dearth of data in Moroccan patients with CKS regarding epidemiology, clinical characteristics and outcomes. This report examines a cohort of patients with CKS evaluated at the national institute of oncology over 11-year period. METHODS: A retrospective analysis of patients referred to the national institute of oncology with classical Kaposi sarcoma, between January 1998 and February 2008, was performed. Reviewed information included demographics, clinical and pathological staging, death or last follow-up. RESULTS: During the study period, 56 patients with a diagnosis of CKS have been referred to our hospital. There were 11(19,7%) females and 45 (80,3%) males (male-to-female ratio: 4:1). Mean age at diagnosis was 61,7 ± 15 (range: 15- 86 years). Nodules and/or plaques were the most frequent type of lesion. The most common location was the lower limbs, particularly the distal lower extremity (90%). In addition to skin involvement, visceral spread was evident in 9 cases. The most common visceral involvement sites were lymph nodes (44%), lung (22%), and gastrointestinal tract (22%). Associated lymphoedema was seen in 24 (42%) of the patients. There were 18 stage I patients (32,14%), 8: stage II (14,28%), 21 stage III(37,5%) and 9 stage IV (16,07%). A second primary malignancy was diagnosed in 6 cases (10,7%), none of the reticuloendothelial system. With a median follow-up of 45 months, 38 (67,8) patients are alive, of whom 25 (65,78%) patients with stable disease, five with progressive disease currently under systemic chemotherapy and 8(21,05%) are alive and free of disease, over a mean interval of 5 years. CONCLUSION: This is the largest reported series in our context. In Morocco, CKS exhibits some special characteristics including a disseminated skin disease at diagnosis especially in men, a more common visceral or lymph node involvement and a less frequent association with second malignancies.
format Online
Article
Text
id pubmed-3266214
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32662142012-01-26 Classic Kaposi's sarcoma in morocco: clinico -epidemiological study at the national institute of oncology Errihani, Hassan Berrada, Narjisse Raissouni, Soundouss Rais, Fadoi Mrabti, Hind Rais, Ghizlane BMC Dermatol Research Article BACKGROUND: Classic Kaposi's sarcoma (CKS) is a rare disease likely associated with human herpes virus 8 (HHV-8) infection, and occurs predominantly in Jewish, Mediterranean and middle eastern men .There is a dearth of data in Moroccan patients with CKS regarding epidemiology, clinical characteristics and outcomes. This report examines a cohort of patients with CKS evaluated at the national institute of oncology over 11-year period. METHODS: A retrospective analysis of patients referred to the national institute of oncology with classical Kaposi sarcoma, between January 1998 and February 2008, was performed. Reviewed information included demographics, clinical and pathological staging, death or last follow-up. RESULTS: During the study period, 56 patients with a diagnosis of CKS have been referred to our hospital. There were 11(19,7%) females and 45 (80,3%) males (male-to-female ratio: 4:1). Mean age at diagnosis was 61,7 ± 15 (range: 15- 86 years). Nodules and/or plaques were the most frequent type of lesion. The most common location was the lower limbs, particularly the distal lower extremity (90%). In addition to skin involvement, visceral spread was evident in 9 cases. The most common visceral involvement sites were lymph nodes (44%), lung (22%), and gastrointestinal tract (22%). Associated lymphoedema was seen in 24 (42%) of the patients. There were 18 stage I patients (32,14%), 8: stage II (14,28%), 21 stage III(37,5%) and 9 stage IV (16,07%). A second primary malignancy was diagnosed in 6 cases (10,7%), none of the reticuloendothelial system. With a median follow-up of 45 months, 38 (67,8) patients are alive, of whom 25 (65,78%) patients with stable disease, five with progressive disease currently under systemic chemotherapy and 8(21,05%) are alive and free of disease, over a mean interval of 5 years. CONCLUSION: This is the largest reported series in our context. In Morocco, CKS exhibits some special characteristics including a disseminated skin disease at diagnosis especially in men, a more common visceral or lymph node involvement and a less frequent association with second malignancies. BioMed Central 2011-11-11 /pmc/articles/PMC3266214/ /pubmed/22078023 http://dx.doi.org/10.1186/1471-5945-11-15 Text en Copyright ©2011 Errihani et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Errihani, Hassan
Berrada, Narjisse
Raissouni, Soundouss
Rais, Fadoi
Mrabti, Hind
Rais, Ghizlane
Classic Kaposi's sarcoma in morocco: clinico -epidemiological study at the national institute of oncology
title Classic Kaposi's sarcoma in morocco: clinico -epidemiological study at the national institute of oncology
title_full Classic Kaposi's sarcoma in morocco: clinico -epidemiological study at the national institute of oncology
title_fullStr Classic Kaposi's sarcoma in morocco: clinico -epidemiological study at the national institute of oncology
title_full_unstemmed Classic Kaposi's sarcoma in morocco: clinico -epidemiological study at the national institute of oncology
title_short Classic Kaposi's sarcoma in morocco: clinico -epidemiological study at the national institute of oncology
title_sort classic kaposi's sarcoma in morocco: clinico -epidemiological study at the national institute of oncology
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266214/
https://www.ncbi.nlm.nih.gov/pubmed/22078023
http://dx.doi.org/10.1186/1471-5945-11-15
work_keys_str_mv AT errihanihassan classickaposissarcomainmoroccoclinicoepidemiologicalstudyatthenationalinstituteofoncology
AT berradanarjisse classickaposissarcomainmoroccoclinicoepidemiologicalstudyatthenationalinstituteofoncology
AT raissounisoundouss classickaposissarcomainmoroccoclinicoepidemiologicalstudyatthenationalinstituteofoncology
AT raisfadoi classickaposissarcomainmoroccoclinicoepidemiologicalstudyatthenationalinstituteofoncology
AT mrabtihind classickaposissarcomainmoroccoclinicoepidemiologicalstudyatthenationalinstituteofoncology
AT raisghizlane classickaposissarcomainmoroccoclinicoepidemiologicalstudyatthenationalinstituteofoncology